Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.15 USD | -2.96% | -0.87% | -48.14% |
May. 08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
May. 08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.14% | 652M | |
+32.12% | 694B | |
+29.39% | 593B | |
-1.61% | 371B | |
+20.01% | 331B | |
+7.05% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.00% | 169B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- Transcript : EyePoint Pharmaceuticals, Inc., Q1 2023 Earnings Call, May 03, 2023